Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex
- 31 October 1994
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 54 (1-2) , 59-68
- https://doi.org/10.1016/0165-5728(94)90231-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytesJournal of Neuroimmunology, 1993
- Development in the thymus: it takes two to tangoImmunology Today, 1993
- The thymic microenvironmentImmunology Today, 1993
- Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide in vitroImmunology Letters, 1992
- Generation and Analysis of Interleukin-4 Deficient MiceScience, 1991
- Cytokines in T-cell developmentImmunology Today, 1991
- Inhibition of mouse T‐cell proliferation by CGRP and VIP: Effects of these neuropeptides on IL‐2 production and cAMP synthesisJournal of Neuroscience Research, 1991
- Human intraepithelial lymphocytesDigestive Diseases and Sciences, 1991
- Specific binding of vasoactive intestinal peptide to human circulating mononuclear cellsCanadian Journal of Physiology and Pharmacology, 1983
- Interaction of vasoactive intestinal peptide with human blood mononuclear cellsMolecular and Cellular Endocrinology, 1981